CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Down 99.9% in February

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 100 shares, a decline of 99.9% from the January 31st total of 89,100 shares. Based on an average daily volume of 75,000 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

Shares of OTCMKTS:CNBX remained flat at $0.01 on Thursday. The stock had a trading volume of 18 shares, compared to its average volume of 85,562. CNBX Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.02. The company’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.